Hemoglobin HbA · PROTEIN COMPLEX · Homo sapiens
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Hemoglobin HbA shows approved-linked disease relevance led by anemia. 5 more disease programs remain visible in the same review block. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt P69905. Start with anemia, then reuse UniProt P69905 as the stable protein anchor across project notes and exports.
Start with anemia, then reuse UniProt P69905 as the stable protein anchor across project notes and exports.
Hemoglobin HbA shows approved-linked disease relevance led by anemia. 5 more disease programs remain visible in the same review block. 1 linked drug remains visible in the same block.
Start review with anemia because it currently carries approved-linked support. Linked drugs include VOXELOTOR. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxyHemoglobin subunit alpha
Review this target as Hemoglobin HbA, mapped to UniProt P69905. ChEMBL maps the protein component as Hemoglobin subunit alpha. Sequence length is 142 aa.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Hemoglobin HbA as ChEMBL target CHEMBL2095168, mapped to UniProt P69905. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Hemoglobin HbA is the right protein anchor across sources, using UniProt P69905 as the stable mapping.
Jump to Protein ContextUse this block first when you need to confirm why anemia is currently framed as approved-linked support. It currently carries 1 linked drug in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Hemoglobin HbA |
| Target Type | PROTEIN COMPLEX |
| Organism | Homo sapiens |
| UniProt | P69905 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Hemoglobin subunit alpha |
| UniProt Accession | P69905 |
| Component Type | Protein |
| Sequence Length | 142 aa |
Hemoglobin subunit alpha
Review this target as Hemoglobin HbA, mapped to UniProt P69905. ChEMBL maps the protein component as Hemoglobin subunit alpha. Sequence length is 142 aa.
Open Targets-ready disease context using the current target-indication evidence contract.
Hemoglobin HbA shows approved-linked disease relevance led by anemia. 5 more disease programs remain visible in the same review block.
Start review with anemia because it currently carries approved-linked support. Linked drugs include VOXELOTOR. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| protein complex format | 22 | 0 | — |
| assay format | 16 | 0 | — |
| tissue-based format | 5 | 0 | — |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 12 | 0 | — |
| tissue-based format | 1 | 0 | — |